Skip to main content
. 2020 Mar 31;24(1):21–28. doi: 10.5213/inj.1938220.110

Fig. 2.

Fig. 2.

The urine glucose level at 12 weeks of treatment. LETO, Long-Evans Tokushima Otsuka; OLETF-CO, control group given water; OLETF-DA, group treated with dapagliflozin at 1.0 mg/kg/day; OLETF-VO, group treated with voglibose at 0.6 mg/kg/day. Values are expressed as the mean±standard error. OLETF-DA, group treated with dapagliflozin at 1.0 mg/kg/day. *P<0.05, OLETF-DA vs. other groups.